IOL Chemicals announces 1:5 stock split; record date soonIOL Chemicals has approved a 1:5 stock split. This will increase affordability and liquidity. Shareholders will receive 5 new shares for ev...
27 Dec, 2024, 07.23 PM IST
Bipolar disorder management: Choosing the right treatment with evidence and real-life impactManaging bipolar disorder can be challenging due to the variety of treatment options and conflicting guidelines. While medication is the ma...
31 Aug, 2023, 06.26 PM IST
IOL to diversify its API and specialty chemicals portfolios to boost salesThe Ludhiana-based company generates about 30% of its ₹2,216 crore revenues from the commodity API ibuprofen, where it is vertically integr...
09 Sep, 2022, 01.45 AM IST
Trending stocks: Cadila Healthcare shares flat in early tradeShares of Cadila Healthcare traded 0.13 per cent up in trade at 10:04 am on Friday .
03 Apr, 2020, 10.08 AM IST
Zydus Cadila gets final nod from USFDA to market generic seizures drugZydus Cadila has received final approval from the United States Food and Drug Administration (USFDA) to market Lamotrigine extended-release...
02 Apr, 2020, 04.24 PM IST
IOL Chemicals hits upper circuit on receiving EUGMP CertificationOn BSE, 1.59 lakh shares exchanged hands in the counter, compared with an average volume of 2.27 lakh shares in the past two week.
13 Apr, 2017, 02.38 PM IST
Twelve stocks in focus on Thursday, 13 April 2017Infosys will announce its financial results for the quarter ended March 31, 2017 on Thursday.
13 Apr, 2017, 08.33 AM IST
Divi’s Laboratories nosedives 20%, hits 52-week low on USFDA’s import alertIn a filing to BSE, the drug marker said that the USFDA has exempted the company from making ten drugs.
21 Mar, 2017, 09.52 AM IST
We have a very ambitious target to reach by 2020: Vijay Kumar Garg, Jt MD, IOL ChemicalsOur plans are that we are not going to increase the debt burden, said Garg.
03 Nov, 2016, 01.24 PM IST
Dr Reddy's launches generic Lamotrigine tablets in USLamictal is indicated as adjunctive therapy for the certain type of seizures and for the maintenance treatment of bipolar disorder.
10 Oct, 2016, 06.01 PM IST
Wockhardt recalls over 50 lakh bottles of various drugs in USAs per the information available on the USFDA, Wockhardt is recalling the drugs for current good manufacturing practice (CGMP) deviations.
03 Aug, 2015, 05.27 PM IST
Twelve stocks in focus in Thursday morning tradeIndian markets are likely to trade in a range. Here is a list of twelve stocks which are likely to remain in focus in morning trade.
27 Jun, 2013, 08.13 AM IST
Dr Reddy's launches anti-epilepsy tablets in US marketDr Reddy's Laboratories said it has launched its generic Lamotrigine extended-release tablets, used for treating epilepsy, in the American ...
26 Jun, 2013, 05.06 PM IST
- Fifteen stocks in focus in Wednesday morning trade
Indian shares are expected to trade in a range. Here is a list of fifteen stocks that are likely to be in action in morning trade today.
09 Jan, 2013, 08.10 AM IST
- Wockhardt gets USFDA nod to market anti-epilepsy tablets
The tablets will be manufactured at the company's facility at Aurangabad.
08 Jan, 2013, 07.32 PM IST
- Glenmark gets USFDA nod for anti-epileptic drug
Glenmark Pharmaceuticals today said its US-based arm has received approval from the US health regulator to market generic Lamictal tablets.
07 May, 2012, 06.50 PM IST
- Lupin gets USFDA nod for lamotrigine tablets
Lupin Ltd said its unit has received US FDA approval for lamotrigine in tablets form.
04 Jun, 2010, 11.13 AM IST